Press "Enter" to skip to content

Atmofizer Technologies Inc. Provides Corporate Update – Harvard, MIT trained Physician Dr. Joshua Helman joins the Board of Directors

Atmofizer Technologies Inc. (CSE: ATMO) (formerly Consolidated HCI Holdings Corporation) (the “Company” or “Atmofizer”) is pleased to provide the following corporate updates.The Company’s common shares (“Common Shares”) commenced trading on the Canadian Securities Exchange (the “CSE”) on Thursday, November 18, 2021. Trading on the CSE commenced following the completion of the reverse takeover of the…

This content is viewable by members only. Visit MY ACCOUNT on the top menu to log in or to register for a 30 day free trial or purchase a subscription for UV Reporter 1 Year Single Membership or UV Reporter 1 Year Group Membership - $189 for first member and $25 for each additional member.